BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 10886591)

  • 1. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
    Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
    Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
    Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.
    Ishikawa N; Miyata T; Ueda Y; Inagi R; Izuhara Y; Yuzawa H; Onogi H; Nishina M; Nangaku M; Van Ypersele De Strihou C; Kurokawa K
    Kidney Int; 2003 Jan; 63(1):331-9. PubMed ID: 12472800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
    Zeier M; Schwenger V; Deppisch R; Haug U; Weigel K; Bahner U; Wanner C; Schneider H; Henle T; Ritz E
    Kidney Int; 2003 Jan; 63(1):298-305. PubMed ID: 12472796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
    van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
    Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
    Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
    Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").
    Miyata T; Sugiyama S; Saito A; Kurokawa K
    Kidney Int Suppl; 2001 Feb; 78():S25-31. PubMed ID: 11168978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
    Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
    Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid.
    Inagi R; Miyata T; Ueda Y; Yoshino A; Nangaku M; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2002 Aug; 62(2):679-87. PubMed ID: 12110033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the peritoneal dialysis prescription on pentosidine in children.
    Bayazit AK; Vogt BA; Dell KM; Davis ID; Noyan A; Anarat A; Avner ED; Erhard P; Weiss MF
    Pediatr Nephrol; 2003 Oct; 18(10):1049-54. PubMed ID: 12898376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation.
    Miyata T; Ueda Y; Asahi K; Izuhara Y; Inagi R; Saito A; VAN Ypersele DE Strihou C; Kurokawa K
    J Am Soc Nephrol; 2000 Sep; 11(9):1719-1725. PubMed ID: 10966497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content.
    Schmitt CP; von Heyl D; Rieger S; Arbeiter K; Bonzel KE; Fischbach M; Misselwitz J; Pieper AK; Schaefer F;
    Nephrol Dial Transplant; 2007 Jul; 22(7):2038-44. PubMed ID: 17420168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
    Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
    Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
    Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
    Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Asymmetric Dimethylarginine and Pentosidine in Dialysis Effluent of Peritoneal Dialysis Patients -A possible intraperitoneal crosstalk between asymmetric dimethylarginine and advanced glycation end products in peritoneal dialysis patients.
    Ishida M; Kakuta T; Miyakogawa T; Tatsumi R; Matsumoto C; Fukagawa M
    Tokai J Exp Clin Med; 2016 Jun; 41(2):97-100. PubMed ID: 27345001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo generation and kinetics of glycosylation products in peritoneal dialysis effluents.
    Yokota S; Kumano K; Hyodo T; Sakai T; Izumi G; Hashimoto A; Shibata K; Wang H
    Adv Perit Dial; 1998; 14():195-9. PubMed ID: 10649723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.
    Miyata T; van Ypersele de Strihou C; Kurokawa K; Baynes JW
    Kidney Int; 1999 Feb; 55(2):389-99. PubMed ID: 9987064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.
    Tauer A; Bender TO; Fleischmann EH; Niwa T; Jörres A; Pischetsrieder M
    Mol Nutr Food Res; 2005 Jul; 49(7):710-5. PubMed ID: 15915443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis.
    Friedlander MA; Wu YC; Elgawish A; Monnier VM
    J Clin Invest; 1996 Feb; 97(3):728-35. PubMed ID: 8609229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.